(Q49096016)

18 February 2018

editorial

0 references

title

How are we creating fluoroquinolone-resistant tuberculosis? (English)

1 reference

18 February 2018

0 references

1

1 reference

18 February 2018

author name string

Wing Wai Yew

series ordinal

2

1 reference

18 February 2018

language of work or name

English

0 references

publication date

1 August 2009

1 reference

18 February 2018

American Journal of Respiratory and Critical Care Medicine

published in

1 reference

18 February 2018

volume

180

1 reference

18 February 2018

issue

4

1 reference

18 February 2018

page(s)

288-289

1 reference

18 February 2018

American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America

cites work

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200906-0863ED

Moxifloxacin versus ethambutol in the first 2 months of treatment for pulmonary tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200906-0863ED

Moxifloxacin versus ethambutol in the initial treatment of tuberculosis: a double-blind, randomised, controlled phase II trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200906-0863ED

Substitution of moxifloxacin for isoniazid during intensive phase treatment of pulmonary tuberculosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200906-0863ED

Trends in fluoroquinolone resistance of Mycobacterium tuberculosis complex in a Taiwanese medical centre: 1995-2003.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200906-0863ED

Empirical treatment with a fluoroquinolone delays the treatment for tuberculosis and is associated with a poor prognosis in endemic areas

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200906-0863ED

Empirical treatment of community-acquired pneumonia and the development of fluoroquinolone-resistant tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200906-0863ED

Fluoroquinolone resistance in Mycobacterium tuberculosis: the effect of duration and timing of fluoroquinolone exposure

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200906-0863ED

Infectious Diseases Society of America/American Thoracic Society Consensus Guidelines on the Management of Community-Acquired Pneumonia in Adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200906-0863ED

Selection of a moxifloxacin dose that suppresses drug resistance in Mycobacterium tuberculosis, by use of an in vitro pharmacodynamic infection model and mathematical modeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200906-0863ED

10.1164/RCCM.200906-0863ED

21 January 2018

Identifiers

DOI

1 reference

18 February 2018

1 reference

18 February 2018